UK Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

UK Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The UK Clinical Nutrition for Diabetes Care Market was valued at $55.90 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $67.73 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Nualtra, Clinova Ltd, and Novo Nordisk among others.

ID: IN10GBPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Avantika Gupta

Buy Now

UK Clinical Nutrition for Diabetes Care Market Executive Summary

The UK Clinical Nutrition for Diabetes Care Market is at around $55.90 Mn in 2023 and is projected to reach $67.73 Mn in 2030, exhibiting a CAGR of 2.78% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.
The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Clinova Ltd is known for its extensive portfolio of medications, including those essential for diabetes care. Amway, Nestlé Health Science, and Fresenius Kabi are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

UK Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

High Prevalence of Diabetes

According to the International Diabetes Federation, the UK has a significant diabetic population, with 4.9 million people living with diabetes as of 2021. This large patient pool creates a strong demand for effective clinical nutrition interventions to manage the condition.

Focus on Preventative Healthcare

The NHS prioritizes preventative healthcare to manage chronic diseases like diabetes. Clinical nutrition can help prevent complications and reduce long-term healthcare costs. There is an increasing awareness among healthcare providers and patients in the UK about the crucial role of effective nutritional strategies in managing diabetes and preventing complications.

Advancements in Nutritional Science

The development of more effective and palatable specialized products catering to the specific needs of diabetic patients, such as high-protein, low-carbohydrate, and fiber-enriched options, is boosting the market growth. These advancements in nutritional science and product formulation are enhancing the ability to better manage blood glucose levels and prevent diabetes-related complications through targeted clinical nutrition interventions.

Market Restraints

High Cost of Specialized Products

Specialized clinical nutrition solutions for diabetes are more expensive than ordinary dietary supplements or conventional foods. The higher cost may pose affordability challenges for some patients, especially those without adequate insurance coverage or financial support, restricting market penetration.

Regulatory Hurdles

The clinical nutrition market is subject to stringent regulations governing the development, manufacturing, and marketing of these specialized products. Navigating the regulatory landscape, obtaining necessary approvals, and ensuring compliance with evolving guidelines can be time-consuming and costly for manufacturers, potentially slowing down market growth.

Accessibility Challenge

Due to the limited availability of registered dietitians in the UK, particularly in rural and minority communities, people with diabetes who need nutritional assessment, counseling and education may find it difficult to access these services, may have problems with diabetes management and growth. of the clinical healthy food market.

Regulatory Landscape and Reimbursement Scenario

National Institute for Health and Care Excellence (NICE) provides evidence-based clinical guidelines for healthcare professionals, including recommendations for the use of clinical nutrition in diabetes management. Health and Care Professions Council (HCPC) regulates dietitians and other healthcare professionals involved in diabetes care. Ensures they meet specific standards and competencies for practice. The Medicines Act 1968 is the legislation for specialized diabetic foods and enteral formulas in the UK. It ensures these products go through a strict approval process before reaching patients. This includes checking safety, quality, and proper labeling for marketing and supply.

For specialized medical food products (FSMPs), reimbursement by the NHS requires product applications that include a proposed price. The NHS aims to reimburse a "fair price" for true innovations that demonstrate improved patient outcomes, rather than paying a premium for non-innovative products. Reimbursement for clinical nutrition services like consultations with dietitians or specialized diabetic foods may vary depending on coverage policy in the region.

Competitive Landscape

Key Players

Here are some of the major key players in the UK Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Nestlé Health Science
Novo Nordisk
Clinova Ltd
Amway
Nualtra
B. Braun Medical Ltd
Reckitt
Fresenius Kabi
Aymes International

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.